Tag: ILT4
Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021...
-Translational analysis of patients that do not respond to PD-(L)1 inhibitors show high pretreatment intratumoral LILRB2 expression relative to an IFNγ gene signature-...